The study was structured as a descriptive cross-sectional investigation of every patient who met the World Health Organization’s suspected-case criteria for mpox and was reported through the Khyber Pakhtunkhwa Integrated Disease Surveillance and Response System, known as KP-IDSRS. Over the study period, 137 suspected cases were flagged by the surveillance network. Of these, 29 were laboratory-confirmed using real-time polymerase chain reaction, the standard molecular diagnostic for orthopoxvirus infection. Samples with sufficiently low cycle threshold values, at or below 23, indicating high viral loads, were selected for whole-genome sequencing on an Illumina iSeq platform, allowing the researchers to reconstruct near-complete viral genomes for phylogenetic analysis.

The demographic profile of the 29 confirmed cases illustrates that mpox in this setting is not confined to any single population group. The median age of patients was 31 years, with ages ranging from an infant of 0.6 years to an adult of 80 years. Twenty patients, or 68.9 percent, were male, eight, or 27.6 percent, were female, and one patient, 3.4 percent, was transgender. This breadth of age and gender stands in contrast to the epidemiology seen in many high-income countries during the 2022 global outbreak, where cases were heavily concentrated among men who have sex with men, and suggests that in Pakistan the routes of introduction and transmission are more varied, driven largely by travel and household contact rather than by a single transmission network.

Classifying each case by likely origin, the investigators found that 13 infections, or 44.8 percent, were imported, meaning the patients acquired the virus abroad and brought it back to Pakistan. Five cases, 17.2 percent, were secondary transmission cases, representing people infected through contact with an imported case. Six cases, 20.7 percent, were classified as locally acquired with no direct epidemiological link to a known imported infection, and a further five, 17.2 percent, were deemed probable local infections. Taken together, the locally acquired and probable local categories account for more than a third of confirmed cases, providing clear evidence that imported mpox viruses have seeded chains of transmission within the province rather than simply arriving and dying out.

Clinically, the illness observed was characteristic of mpox but generally mild. A vesiculopustular rash, the hallmark dermal manifestation of orthopoxvirus infection in which fluid-filled vesicles evolve into pus-filled pustules before crusting over, was present in all 29 confirmed cases, a 100 percent frequency. Fever was recorded in 82.8 percent of patients, musculoskeletal pain in 37.9 percent, genital or perianal lesions in 34.5 percent, and sore throat in 24.1 percent. The presence of genital and perianal lesions in roughly a third of cases is notable because such lesions can be mistaken for other sexually transmitted infections, delaying diagnosis and isolation. Most patients recovered completely, but the study also records two deaths among the confirmed cases, a somber reminder that even in a largely mild outbreak, mpox carries real mortality risk, particularly for vulnerable patients.

The genomic component of the study is where its significance is most pronounced. Whole-genome sequencing of four representative cases identified both Clade IIb viruses, specifically of lineage A.2.1, and Clade Ib viruses. Mpox virus, an enveloped double-stranded DNA virus of the genus Orthopoxvirus, was long divided into two major clades, with the former Congo Basin or Clade I lineage generally associated with more severe disease and the West African or Clade II lineage with milder illness. The nomenclature has since been refined: Clade IIb denotes the lineage responsible for the sustained human-to-human global spread that began in 2022, while Clade Ib is a recently emerged branch of Clade I that has driven outbreaks in the Democratic Republic of the Congo and neighboring countries and prompted the WHO to declare a second mpox Public Health Emergency of International Concern in 2024. Detecting Clade Ib in a non-endemic country is therefore a marker of how far this newer lineage has traveled.

Phylogenetic analysis of the Pakistani genomes revealed close genetic relationships with sequences reported from within Pakistan itself and from the United States, Nepal, and Thailand. This pattern of clustering across widely separated countries is consistent with the well-established role of international travel in moving mpox virus between continents. Pakistan’s particular vulnerability stems from extensive labor migration to Gulf countries, which creates a constant flow of travelers between South Asia and regions where mpox introductions occur. Each returning traveler represents a potential introduction event, and with limited decentralized diagnostic capacity, infections can go unrecognized until secondary cases appear, exactly the pattern the epidemiological classifications in this study document.

The laboratory work underpinning these findings reflects a coordinated public health infrastructure operating under real constraints. Specimens were processed at the Khyber Pakhtunkhwa Public Health Reference Laboratory at Khyber Medical University in Peshawar, with sequencing support from the National Institutes of Health in Islamabad. The workflow, from standardized surveillance forms through real-time PCR confirmation to genome assembly and phylogenetic comparison against international databases, demonstrates that a provincial reference laboratory in a resource-limited setting can generate genomic data of direct global relevance. The authors acknowledge the WHO and the Khyber Pakhtunkhwa Health Department for supplying diagnostic kits and consumables, and note that the study received no formal external funding, underscoring how much of this surveillance was sustained through institutional commitment rather than dedicated program budgets.

The public health implications of co-circulating clades are substantial. When two genetically distinct lineages circulate simultaneously, each introduction event must be traced independently, and genomic surveillance becomes essential for distinguishing imported cases from established local transmission chains. A locally acquired Clade Ib case, in particular, signals that the newer lineage has achieved at least limited autonomous transmission in the province. The authors argue that this evidence makes a case for strengthened genomic surveillance, decentralized diagnostics that can confirm cases outside a single reference laboratory, and improved access to vaccines and therapeutics. Vaccines such as the Modified Vaccinia Ankara Bavarian Nordic product, which is used for mpox prevention in many countries, remain limited in availability across much of South Asia, and expanding access is a policy challenge that extends well beyond laboratory walls.

For the broader scientific community, the study adds an important data point to the global map of the ongoing mpox emergency. It shows that Clade Ib has reached South Asia and established detectable local transmission there, that Clade IIb lineage A.2.1 continues to circulate in the same region, and that a surveillance system built on WHO case criteria, rapid response teams, and provincial laboratory capacity can detect and characterize this diversity. As international travel continues to connect endemic and non-endemic regions, the Pakistani experience illustrates a pattern likely to recur elsewhere: imported cases are inevitable, but whether they fade out or ignite sustained transmission depends on how quickly diagnostics, contact tracing, vaccination, and genomic sequencing can be brought to bear. The findings from Khyber Pakhtunkhwa suggest that in much of the world, that capacity still needs deliberate investment before the next introduction arrives.

Subject of Research: Emergence and co-circulation of Clade Ib and Clade IIb mpox virus in a non-endemic region of Pakistan

Article Title: Emergence and co-circulation of Clade Ib and Clade IIb Mpox viruses in Khyber Pakhtunkhwa Pakistan, 2024–2026: clinical, genomic, and public health insights from a non-endemic region

Article References: Zia, A., Islam, A., Jamal, Z., Khan, M., Khattak, A. A., Manzoor, M., Umair, M., Muhammad, A., Mehmood Noor, S., Rehman, K., Zohaib, A., Khan, M. A., & Yousafzai, Y. M. (2026). Emergence and co-circulation of Clade Ib and Clade IIb Mpox viruses in Khyber Pakhtunkhwa Pakistan, 2024–2026: clinical, genomic, and public health insights from a non-endemic region. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14542-6

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14542-6

Keywords: mpox, Clade Ib, Clade IIb, orthopoxvirus, whole-genome sequencing, genomic surveillance, Pakistan, Khyber Pakhtunkhwa, travel-associated infections, public health, epidemiology, emerging infectious diseases

The stakes of this kind of work are hard to overstate. In the past two decades, three zoonotic coronaviruses—SARS-CoV-1, MERS-CoV, and SARS-CoV-2—have caused major outbreaks, and each emergence began with a virus crossing a species barrier. For sarbecoviruses, that barrier is defined largely by compatibility between the viral receptor-binding domain (RBD) on the spike protein and the host’s angiotensin-converting enzyme 2 (ACE2) receptor. If a virus’s RBD can engage a species’ ACE2 efficiently, that species becomes a plausible host; if it cannot, the chain of transmission breaks at the very first step. Understanding which receptors are vulnerable to which viruses is therefore central to anticipating where the next spillover might come from.

To build the atlas, the researchers first established an evolutionary framework. Phylogenetic analysis of the RBD sequences divided the 46 viruses—31 from bats, 10 from humans, three from civets, and two from pangolins—into three major clades, with clade 1 further splitting into subclades 1a and 1b. Clade 1a contains SARS-CoV-1 and related bat and civet strains; clade 1b contains SARS-CoV-2 and its closest relatives, including the bat virus RaTG13 and pangolin coronaviruses. Clade 2, which comprises most known sarbecoviruses, carries a distinctive double-segment deletion in the receptor-binding motif, while clade 3 viruses from African and European bats carry a single-segment deletion in the same region. These structural differences in the RBM, the loop that physically contacts ACE2, turned out to predict much of the functional variation the team later observed.

The functional screen itself relied on pseudotyped reporter viruses: vesicular stomatitis virus particles decorated with each sarbecovirus spike protein, whose entry into cells expressing a given ACE2 ortholog could be quantified by luminescence. The team confirmed comparable spike expression and incorporation across pseudovirus preparations by western blot and normalized viral input by quantitative RT-PCR, allowing a fair comparison across the roughly 3,000 possible virus-receptor pairings. The result is a heatmap of cross-species infectivity that functions as a kind of vulnerability index for each species’ receptor.

Clade 1 viruses emerged as the clear standouts in receptor breadth. Within clade 1b, the pangolin viruses PCoV-GD and PCoV-GX, which share 89.6 and 92.3 percent spike identity with SARS-CoV-2 respectively, showed broad ACE2 compatibility, with PCoV-GD efficiently infecting nearly all tested non-bat mammalian ACE2s and most bat ACE2s. Intriguingly, RaTG13—despite sharing 97.4 percent identity with SARS-CoV-2 across the full spike protein—displayed a more restricted host range, implying that subtle differences within the receptor-binding motif underlie the expanded tropism of SARS-CoV-2. Within clade 1a, human SARS-CoV-1 isolates used ACE2 orthologs from a wide range of bat families, whereas most bat- and civet-derived relatives showed narrower usage, with the bat virus WIV1 bridging human and bat lineages through its ability to engage ACE2 from multiple Rhinolophus and Myotis species.

Clade 2 and clade 3 viruses told very different stories. None of the clade 2 pseudoviruses, which represent the majority of known sarbecoviruses, mediated entry through any of the 66 ACE2 orthologs, consistent with their double RBM deletion and previously reported ACE2-independent entry mechanisms. Clade 3 viruses showed intermediate phenotypes: BtKY72 used ACE2 from only a few Rhinolophus species and did not engage human ACE2, while Khosta-2 showed broader tropism, infecting cells expressing rabbit ACE2 more than ten-fold more efficiently than those expressing the human receptor—a striking example of lineage-specific adaptation.

The study also delivered a decisive verdict on several proposed alternative receptors. Host factors including NRP1, CD147, AXL, and TMEM106B have each been suggested to facilitate SARS-CoV-2 entry in various experimental contexts. Yet across the entire 46-virus panel, none of these factors supported detectable infection when overexpressed in the assay cells, indicating that none functions as an independent entry receptor for any sarbecovirus tested. The authors are careful to note that context-dependent accessory roles in specific SARS-CoV-2 settings cannot be excluded, but the message is clear: ACE2 remains the only demonstrated primary entry receptor across this viral diversity.

Among the most consequential findings is the identification of two bat species whose receptors behave remarkably like the human version. Only the ACE2 orthologs of Rhinolophus affinis and Miniopterus schreibersii correlated strongly with human ACE2 usage across the viral panel, with correlation coefficients of 0.8314 and 0.8777 respectively. Surface plasmon resonance confirmed that M. schreibersii ACE2 binds the SARS-CoV-1 and SARS-CoV-2 RBDs with high affinity—dissociation constants of 8.14 × 10⁻⁸ M and 8.06 × 10⁻⁷ M, lower than human ACE2’s nanomolar binding but fully consistent with efficient entry. Because both species range across Southeast Asia, Europe, and North Africa in regions overlapping human habitats, the authors argue they should be priorities for ongoing surveillance. The data also flagged rabbits, cattle, sheep, raccoon dogs, badgers, Siberian chipmunks, and pigs as mammalian species whose ACE2 usage correlates strongly with human ACE2, marking them as candidate intermediate hosts worth investigating.

Perhaps the most mechanistically revealing part of the study concerns two closely related Miniopterus bats whose receptors sit at opposite ends of the permissiveness spectrum. M. schreibersii ACE2 supported entry by nearly all ACE2-dependent pseudoviruses, while the ACE2 of M. natalensis was entirely non-permissive—despite the two proteins differing by only seven amino acids. Three of those substitutions, at positions 27, 31, and 42, sit directly at the predicted RBD-binding interface. Molecular dynamics simulations using the molecular mechanics generalized Born surface area method showed that mutating M. schreibersii ACE2 residue I27 to lysine raised the binding free energy by roughly 5 kcal/mol, while the K42E substitution raised it by nearly 7 kcal/mol, disrupting a salt-bridge network involving residue D38 and the SARS-CoV-1 RBD residue Y442. Entry assays confirmed the simulations: the I27K mutation selectively impaired civet-derived SARS-CoV-1 entry, N31G had minimal impact, and K42E broadly abolished usage by nearly all pseudotypes. Reciprocally, introducing the corresponding M. schreibersii residues into M. natalensis ACE2 restored entry competence for multiple SARS-CoV-1 pseudotypes. Residues 27 and 42, in short, are the principal molecular switches governing Miniopterus receptor recognition.

The authors are candid about the limits of their approach. Pseudoviruses built from available sequences may not capture the full diversity of natural sarbecoviruses, and receptor compatibility is only one barrier to cross-species transmission; protease availability, replication competence, and immune evasion all matter for productive infection in a living animal. Efficient ACE2 engagement alone does not guarantee disease. Still, the atlas provides exactly the kind of mechanistic framework that field surveillance has lacked: a way to prioritize which of the world’s more than 1,400 bat species, and which of the hundreds of circulating sarbecovirus sequences, warrant the closest monitoring. As the authors put it, identifying species with ACE2 structures resembling the human receptor may help focus receptor-based risk assessment where it matters most—before, rather than after, the next spillover.

Subject of Research: Cross-species ACE2 receptor usage and host-range determinants of sarbecoviruses

Article Title: An atlas of sarbecovirus infectivity across diverse ACE2 orthologs

Article References: Sun, Y., Cheng, Z., Wu, X., Liu, K., Wang, L., Yang, D., Huang, W., & Nie, J. (2026). An atlas of sarbecovirus infectivity across diverse ACE2 orthologs. iScience, 29(10), Article 117769. https://doi.org/10.1016/j.isci.2026.117769

Image Credits: AI Generated

DOI: 10.1016/j.isci.2026.117769

Keywords: sarbecovirus, ACE2, SARS-CoV-2, SARS-CoV-1, bats, spillover, pseudovirus, receptor-binding domain, host range, surveillance, Miniopterus, Rhinolophus

The research focused on two broad categories of pathogens that dominate concerns about emerging infections. The first are zoonotic diseases, those that spill over directly from animals into human populations, a group that includes some of the most feared pandemic threats of the modern era, such as coronaviruses, Ebola and mpox. The second are vector-borne diseases, which are transmitted to humans through the bites of infected mosquitoes, ticks and fleas, and which include major public health burdens such as dengue, Lyme disease and malaria. By analysing outbreak records for both groups at a global scale, the researchers hoped to identify whether a common set of environmental conditions underlies the well-documented rise in emerging infectious diseases over recent decades.

What they found was a clear anthropogenic fingerprint on the global geography of disease emergence, but one whose details differ sharply between disease types. For outbreaks overall, risk was generally higher in places where people and their livestock live in close proximity to highly fragmented forested ecosystems. Fragmentation, in this context, describes a familiar pattern of landscape change: a once-contiguous forest carved into many smaller woodlands, separated by farms, roads and human settlements. These patchwork landscapes tend to favour certain animal species that thrive at the edges between wild and human-dominated terrain, and many of those resilient species are more likely to carry pathogens. At the same time, people living in or near these fragmented habitats are more likely to encounter the animals, creating more opportunities for pathogens to make the jump into human populations.

For vector-borne diseases in particular, the evidence of human influence was especially clear. The analysis showed increased risks of outbreaks of diseases such as dengue and Zika in areas with fragmented ecosystems, and also in regions experiencing long-term declines in rainfall attributable to climate change. This connection between shifting precipitation patterns and mosquito-borne disease risk adds to a growing body of concern among public health researchers, because rainfall shapes the availability of the standing water that mosquitoes need to breed, and changing climate conditions can expand the geographic range and seasonal activity of vector species. The finding suggests that as climate change alters rainfall regimes across the tropics and subtropics, the threat from diseases like dengue and Zika may continue to grow in ways that are directly traceable to human activity.

Yet the picture for zoonotic infections proved far more complicated, and this complexity may be the study’s most consequential finding. For diseases that spill over directly from animals to people, including many of the pathogens considered the greatest pandemic threats, the researchers found no environmental factors that consistently helped to predict where outbreaks occur. The effects of deforestation, climate warming and agricultural intensification varied considerably from one disease to another, defying any attempt to draw a single map of global spillover risk. This variability challenges a widespread assumption that a common set of environmental drivers, such as forest loss or warming temperatures, lies behind the rise of emerging infectious diseases as a whole. Instead, the authors argue, meaningful progress will require disease-specific and region-specific data to monitor potential outbreak risks, an approach that is more demanding but far better matched to the messy reality of how pathogens actually move between animals and humans.

Lead author Dr Rory Gibb of the UCL People and Nature Lab emphasised this point in comments accompanying the release. Our findings show that no single environmental recipe can predict where emerging infectious disease outbreaks will occur, he said. Disease transmission from animals to people is common in human-modified habitats worldwide, but the exact human activities that drive outbreaks differ between diseases. He added that this variability makes it critically important to improve people’s access to healthcare and to strengthen disease monitoring systems, so that outbreaks of any disease can be detected early and stopped before they escalate into epidemics or pandemics. In other words, rather than betting on a predictive map of the next spillover, the safest strategy is to build systems capable of catching outbreaks wherever they arise.

One of the study’s most striking and potentially policy-changing results concerns not where outbreaks happen, but where they are noticed. The researchers found that the odds of an emerging disease outbreak being reported fell by an average of 32 percent for every additional hour of travel to the nearest healthcare facility. This finding demonstrates the critical role that healthcare access plays in determining where outbreaks are detected, and it carries an uncomfortable implication for how the world has understood disease emergence. Many of the apparent hotspots highlighted in previous global analyses may reflect less about where infections actually occur and more about where disease surveillance and healthcare systems are currently strongest. Regions with poor healthcare access, often the very places where ecological change is rapid, may be silently absorbing outbreaks that never enter the global record, leaving the international community with a distorted picture of the true geography of risk.

Co-author Professor Sadie Ryan of the University of Florida framed the broader lesson as a call for integration. Spillover disease outbreaks are multi-causal, shaped by the socioecological system, she said, adding that this really highlights the need for One Health integrated approaches to surveillance and intervention, because there is no single intervention strategy. The One Health framework, which recognises that the health of humans, animals and ecosystems are inseparably linked, has gained momentum in global health circles in recent years, and this study provides some of the strongest quantitative support yet for that perspective. If the drivers of emergence differ from disease to disease, then prevention cannot rely on any single lever, whether forest conservation, vaccination, or mosquito control alone, but must instead combine interventions tailored to local ecological and social conditions.

The authors of the Nature paper accordingly call for a more proactive and holistic approach to preventing epidemics and pandemics, one that combines the strengthening of health systems, global coordination of disease surveillance, and ecosystem-based interventions targeted at the most important diseases. Such an agenda would represent a significant shift from the reactive posture that has characterised much of the world’s response to emerging infections, in which resources flood toward a pathogen only after it has already caused a crisis. The study team was led by scientists at UCL, the University of Florida and Yale University, and the research was supported by a US National Science Foundation Biology Integration Institute grant to the Verena Institute, reflecting the interdisciplinary effort required to link ecology, climatology and epidemiology at a global scale.

As human populations continue to expand into fragmented habitats and climate change redraws the maps of rainfall and temperature, the pressures documented in this study are set to intensify. The research does not offer the comfort of a simple predictive rule, but it offers something arguably more valuable: a realistic account of how human activity shapes disease emergence, an honest accounting of the blind spots created by unequal healthcare access, and a clear argument that early detection and strong health systems are the most reliable defence available. In an era when the next outbreak may come from any of dozens of pathways, that message, that vigilance must be broad, locally informed and globally coordinated, may prove to be the study’s most enduring contribution to global public health.

Subject of Research: Environmental drivers of emerging zoonotic and vector-borne infectious disease outbreaks

Article Title: How human impacts increase risk of emerging infectious disease outbreaks

Article References: How human impacts increase risk of emerging infectious disease outbreaks. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: emerging infectious diseases, zoonotic spillover, vector-borne disease, deforestation, ecosystem fragmentation, climate change, dengue, disease surveillance, One Health, healthcare access, Nature, global health

The Marburg virus (MARV) and its sibling, the Ravn virus (RAVV), both members of the Filoviridae family, are culprits behind sporadic yet often devastating viral hemorrhagic fever outbreaks. These viruses share remarkable genetic and structural similarities, particularly in their surface glycoproteins that facilitate cellular entry. Despite this kinship, subtle antigenic differences have historically hampered the development of broadly reactive therapeutics. The recent study by Saito et al. breaks this impasse, demonstrating how specific antibody candidates can surmount these molecular challenges, binding effectively to conserved epitopes present on both viruses.

Crucial to this breakthrough was the sophisticated screening methodology employed to sift through an extensive repertoire of B cells derived from survivors and immunized models. Using state-of-the-art single-cell sequencing and high-throughput binding assays, the investigators mapped the antibody landscape with unprecedented resolution, isolating rare antibodies with dual-binding affinities. This fine specificity against conserved viral regions suggests these antibodies neutralize critical functional aspects of the viral entry machinery, thereby halting infection at its earliest stage.

Structural elucidation using cryogenic electron microscopy (cryo-EM) revealed that these antibodies target a highly conserved domain within the viral glycoprotein, imparting cross-reactivity. The glycoprotein, responsible for mediating viral fusion and host cell entry, presents a dynamic and complex conformation that has, until now, eluded broadly neutralizing antibodies. The structural snapshots provided by the researchers have unraveled the precise molecular architecture, demonstrating how antibody binding induces conformational changes that preclude viral membrane fusion.

Beyond structural insights, functional assays confirmed the neutralizing potency of the isolated antibodies in vitro. When introduced into cell cultures infected by either Marburg or Ravn viruses, these antibodies markedly inhibited viral replication. Notably, the neutralization efficacy was observed at nanomolar concentrations, underscoring their therapeutic feasibility. Moreover, experiments in animal models of infection provided compelling evidence that passive transfer of these antibodies confers protection against lethal viral challenge, dramatically improving survival rates and mitigating disease pathology.

A particularly encouraging aspect of this study lies in the potential therapeutic application of these antibodies. Currently, treatment options for filovirus infections remain limited, with high mortality rates prompting urgent calls for novel interventions. The cross-neutralizing antibodies identified here are strong candidates for antibody-based therapeutics and may serve as templates for vaccine design. Their ability to target multiple strains reduces the likelihood of escape mutants, enhancing their robustness as countermeasures in outbreak settings.

Moreover, the study enhances our understanding of viral evolution and immune evasion mechanisms. By pinpointing conserved regions vulnerable to antibody attack, it charts a new course for rational immunogen design aimed at eliciting broad protective responses in vaccinated individuals. This approach contrasts with traditional strategies that often target highly variable viral epitopes, which quickly mutate under immune pressure.

The research also raises intriguing questions about the immune landscape during natural infection and vaccination. The rarity of such broadly neutralizing antibodies implies that their induction may require precise immunological conditions or specific antigen exposure sequences. Understanding these parameters will be pivotal for optimizing future vaccine platforms capable of reproducing these protective humoral responses.

In terms of public health impact, the discovery carries profound implications. Marburg virus disease, although less well known than Ebola, poses a significant threat in parts of Africa where outbreaks have occurred sporadically but with devastating consequences. The prospect of a broadly effective antibody therapy, or a vaccine inspired by these antibody targets, offers hope for curbing transmission and reducing the burden of fatal hemorrhagic fever outbreaks.

The translational potential of these findings is underscored by the robust pipeline established for antibody development. The isolated antibodies have already been humanized and optimized for increased stability and half-life, critical features for clinical application. Early pharmacokinetic and safety studies suggest favorable profiles, paving the way for clinical trials and accelerated regulatory pathways in the face of emerging filovirus epidemics.

Furthermore, the study’s integrative approach combining immunology, structural biology, and virology exemplifies the interdisciplinary efforts required to tackle complex infectious diseases. By bridging the knowledge gaps across these domains, the researchers have set a benchmark for future endeavors aimed at combating other high-threat pathogens with similar molecular complexity.

While the immediate focus rests on Marburg and Ravn viruses, the principles derived may extend to other members of the filovirus family, including Ebola. Cross-neutralization studies remain ongoing, with preliminary data suggesting that some antibodies may exhibit a broader spectrum of activity than initially anticipated. This prospect raises the exciting opportunity for a universal filovirus therapeutic or vaccine, a holy grail in the field.

The identification of these antibodies also invites exploration into combination therapies. Potential synergies between monoclonal antibodies and small molecule antivirals, or immune modulators, could further enhance treatment outcomes. Tailoring such regimens will depend on detailed mechanistic insights, some of which this study contributes, revealing key vulnerabilities in viral entry processes.

In conclusion, Saito and colleagues’ pioneering work represents a monumental leap forward in antiviral antibody discovery, charting a route toward effective, broad-spectrum interventions against deadly hemorrhagic viruses. Their study underscores the profound power of cutting-edge molecular and cellular technologies in unveiling therapeutic gold mines within the human immune response. As the global community braces for future viral threats, such innovations illuminate the path to safer, more effective countermeasures that could save countless lives.

Subject of Research: Cross-neutralizing antibodies against Marburg and Ravn viruses with therapeutic potential.

Article Title: Discovery of potent cross-neutralizing antibodies against Marburg and Ravn viruses with therapeutic potential.

Article References:
Saito, T., Miyamoto, H., Igarashi, M. et al. Discovery of potent cross-neutralizing antibodies against Marburg and Ravn viruses with therapeutic potential. npj Viruses 3, 84 (2025). https://doi.org/10.1038/s44298-025-00168-z

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s44298-025-00168-z

Historically endemic to regions including Africa, the Balkans, the Middle East, and much of Asia, CCHFV has recently demonstrated a marked capacity for geographic expansion. One of the principal contributing factors to this trend is the virus’s transmission through ticks, specifically Hyalomma species, which are carried by migratory birds. This mode of dissemination allows the virus to infiltrate new territories, notably Western Europe, thereby elevating the risk of outbreaks in previously unaffected populations. The increasing range of the virus highlights the dynamic interplay between ecological factors and pathogen propagation.

At the forefront of combating this expanding threat is Professor Scott Pegan from the University of California, Riverside School of Medicine. Awarded a substantial grant from the National Institutes of Health totaling approximately $3.4 million over five years, Pegan is spearheading an international, multi-institutional consortium dedicated to the identification and development of broadly protective antibodies against CCHFV. This initiative is poised to make critical strides towards therapeutic interventions in a pathogen realm currently devoid of effective options.

The viral agent is deemed a priority pathogen not only by American institutions but also by the World Health Organization. CCHFV functions as the prototypical virus within the nairovirus genus, a taxonomic grouping that also encompasses other emergent nairoviruses such as Benji, Songling, Wetland, Yezo, and the Pacific Coast tick nairovirus. Each of these viruses poses distinct yet interconnected challenges, making the CCHFV a pivotal focus for understanding nairoviral pathogenesis and immune evasion mechanisms.

Pegan emphasized the urgency created by the virus’s rapid dissemination and severe clinical outcomes: “This project is designed to identify broadly protective antibody candidates that can be developed into therapies to combat CCHFV infections.” This statement underscores the interdisciplinary essence of the research, aimed at unraveling the complexities of host immune responses and exploiting them therapeutically. The project’s ambitious goals extend beyond treatment to inform foundational knowledge about immune targeting of viral epitopes.

The investigative team comprises experienced virologists and immunologists across multiple esteemed institutions, including co-principal investigator Dr. Mohammad Sajadi of the University of Maryland School of Medicine. The involvement of researchers from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), such as Aura Garrison and Joseph Golden, brings decades of expertise in hemorrhagic fever virus research. This collaborative structure facilitates a convergence of cutting-edge technical skill sets in molecular virology, immunology, and translational therapeutics.

A key component of their work involves analyzing immune profiles of CCHFV survivors originating from endemic settings in Kazakhstan, Turkey, and Uganda. These regions represent distinct viral genetic lineages and epidemiological contexts, lending the research a broad relevance. By isolating and characterizing neutralizing antibodies from convalescent individuals, the team aims to identify monoclonal antibodies capable of cross-neutralizing diverse CCHFV strains. Such therapeutic monoclonals mimic the immune system’s natural viral defense mechanisms, offering promise as both prophylactic and post-exposure countermeasures.

Technically, the project involves advanced methodologies such as epitope mapping to pinpoint immunodominant regions of viral proteins that elicit potent antibody responses. These epitopes serve as molecular targets to engineer monoclonal antibodies with enhanced binding affinity and breadth. The approach also incorporates structural virology techniques, including cryo-electron microscopy and X-ray crystallography, to elucidate the three-dimensional conformation of viral glycoproteins involved in host cell entry and immune recognition.

Understanding how the immune system counteracts CCHFV is crucial not only for therapy but also for vaccine design, which remains elusive given the virus’s antigenic diversity and complex replication cycle. By targeting non-traditional viral proteins that have historically received less attention, the research has the potential to reveal vulnerable “Achilles’ heels” within the viral arsenal. These novel insights could revolutionize the development of broadly protective interventions against CCHFV and related nairoviruses.

Beyond basic scientific exploration, the project embodies a multidisciplinary and international effort encompassing institutions such as the Centers for Disease Control and Prevention, Rocky Mountain Laboratories, the Uganda Virus Research Institute, Hitit University in Turkey, and the South Kazakhstan Medical Academy. This global partnership reflects the recognition that CCHFV’s threat surpasses borders and requires concerted, cross-sectoral responses integrating epidemiology, clinical science, and biodefense.

Pegan’s vision articulates a strategic framework for tackling not only the current CCHFV threat but also impending nairovirus outbreaks that may emerge due to ecological change and increasing human-wildlife interface. “By utilizing a non-traditional targeting strategy,” Pegan noted, “the project could lead to novel, potentially life-saving therapeutics and establish a valuable paradigm for future viral hemorrhagic fever research.” This emphasis on innovation and preparedness resonates deeply in an age increasingly cognizant of viral pandemic risks.

The epidemiological complexities of CCHFV also bear relevance to its zoonotic and vector-borne characteristics; the virus perpetuates in nature through a tick-vertebrate-tick transmission cycle involving various wild and domestic animals. These animal reservoirs sustain viral endemicity and facilitate spillover events into human populations. The amplification of infected tick vectors, their adaptation to new environments, and anthropogenic factors such as land use change collectively drive the observed expansion of CCHFV’s geographic footprint.

From a molecular standpoint, CCHFV is an enveloped negative-sense single-stranded RNA virus with a segmented genome. The virus encodes several structural and non-structural proteins integral to its replication and pathogenicity. Particularly, the viral glycoprotein precursor undergoes cleavage to form mature glycoproteins that mediate host receptor engagement, membrane fusion, and immune evasion. These proteins are prime targets for neutralizing antibodies and represent focal points of the ongoing therapeutic antibody discovery efforts.

In light of the looming threat posed by CCHFV and the lack of effective countermeasures, the advent of this comprehensive research initiative marks a critical juncture. The integration of advanced immunological tools, structural biology, and field epidemiology promises to expedite therapeutic development. This endeavor not only addresses an urgent public health need but also contributes to the broader scientific pursuit of combating viral hemorrhagic fevers, which continue to challenge global health security.

Subject of Research: Development of broadly protective monoclonal antibodies against Crimean-Congo hemorrhagic fever virus (CCHFV) and understanding immune responses to the virus in endemic populations.

Article Title: International Effort Accelerates Development of Therapeutic Antibodies to Combat Expanding Threat of Crimean-Congo Hemorrhagic Fever Virus

News Publication Date: Not specified in the source content

Web References:
– https://www.who.int/news-room/fact-sheets/detail/crimean-congo-haemorrhagic-fever
– https://profiles.ucr.edu/app/home/profile/scottp
– https://medschool.ucr.edu/
– http://www.ucr.edu/

References: National Institutes of Health grant announcement (details within the article content); original research outlined by Prof. Scott Pegan and team; institutional information from University of California, Riverside and partnering agencies.

Keywords: Crimean-Congo hemorrhagic fever virus, CCHFV, nairovirus, monoclonal antibodies, viral hemorrhagic fever, emerging infectious diseases, antibody therapeutics, biosafety level 4 pathogen, vector-borne virus, tick-borne diseases, viral immunology, NIH research grant.

This pioneering symposium was designed with the vision to drive forward biomedical innovation through cross-disciplinary dialogue and global partnership. It served as a catalyst for nurturing collaborative research networks that address pervasive human health concerns such as climate change-related health effects, emerging infectious diseases, and persistent global health disparities. The event was more than a gathering; it was a concerted effort to harness diverse academic expertise and clinical insights to forge a future where science directly benefits humanity.

The intense opening session, overseen by Professor Sun Wook Hwang, Vice Dean of Research, plunged into “Therapeutic Mechanisms for Clinical Translation.” Distinguished presentations explored the molecular and cellular pathways involved in hepatocellular carcinoma progression, highlighting the urgent need for novel therapeutic approaches. Additionally, the discussion illuminated the promise held by low-cost, natural product-derived treatments intended particularly for resource-limited settings, underscoring the global imperative of equitable healthcare solutions. Speakers such as Professor Henry Chan from The Chinese University of Hong Kong and Professor Olaniyan Tope of Nigeria’s Kwara State University led these discussions, integrating clinical research with practical application considerations.

The symposium’s second theme, “Biomedical Convergence for Global Healthcare,” chaired by Professor Sung Gu Kang from the Korea University Anam Hospital’s Department of Urology, underscored the transformative potential of integrating engineering, molecular biology, and clinical medicine. Among the diverse topics discussed were international cooperative efforts in prostate cancer research and the intricate vascular biology underlying disease pathogenesis. Contributors included leading figures such as Professor Isaac Kim of Yale School of Medicine and Professor Hanjoong Jo of Georgia Tech. Their work demonstrated how converging disciplines can accelerate innovative drug development and enhance strategies for combating complex diseases on a global scale.

Broadening the scope, the third session—“Integration of Health Policy & Human Behaviors,” under the leadership of Professor Eunsoo Choi from the Department of Psychology—examined the interplay between policy frameworks, behavioral sciences, and epidemiology. Presentations delved into cardiovascular risk factor management strategies influenced by psychosocial determinants, spatial social psychology’s role in community health, resilience mechanisms to climate-change-induced pandemics, and cutting-edge research in human virology. Esteemed scholars such as Professor Lentflow from the University of Cambridge and Professor Waheed from Pakistan’s National University of Sciences and Technology contributed insights that meld policy analysis with behavioral health to optimize preventive and therapeutic interventions worldwide.

Korea University’s faculty members across a broad spectrum of basic and clinical science disciplines actively engaged in the symposium, enriching the discourse through their expertise. Vice Dean of Academic Affairs Hyeon Soo Kim (Department of Anatomy), Professor Man-Seong Park (Microbiology), and Professor Jee Hoon Roh (Physiology) participated in dynamic sessions. Clinical specialists including Professor Sung-soo Park (Surgery), Professor Ki Jin Ryu (Obstetrics and Gynecology), Professor Jinwoo Park (Neurology), and Professor Sun Young Yim (Gastroenterology) contributed critical perspectives that bridged foundational science with patient-centered care. Their involvement highlighted the institution’s commitment to holistic biomedical education and research.

Graduate students also played a pivotal role in the symposium by presenting posters and engaging in interactive discussions. This inclusion demonstrated the academic vigor of Korea University’s medical community and its dedication to fostering the next generation of physician-scientists and biomedical researchers. Their participation ensured that emerging ideas and fresh perspectives influenced ongoing dialogues about advancing human health through innovation and collaboration.

In his keynote address, Dean Seong Bom Pyun articulated a compelling vision for Korea University College of Medicine. Emphasizing the dismantling of disciplinary and geographic silos, he underscored the necessity of multidisciplinary, international partnership to effectively confront global health crises. Dean Pyun acknowledged the invaluable contributions from partner institutions including Yale School of Medicine and the National University of Singapore School of Medicine. These collaborations aim to cultivate highly skilled physician-scientists and expand student exchange initiatives, thereby creating a fertile environment for shared knowledge and resources.

The event’s conclusion featured remarks from Dean Jae-yong Park of the College of Health Science, who expressed hope that the K-CLUB platform would stimulate ongoing knowledge exchange and propel innovations in healthcare both within Korea and internationally. He anticipated that the rich discussions from this inaugural symposium would translate into concrete collaborative research efforts, fostering tangible improvements in clinical practice and biomedical technology.

Looking to the future, Korea University College of Medicine intends to leverage the momentum generated by the K-CLUB International Symposium to solidify its position as a leading global research institution. The college plans to deepen ties with distinguished scholars worldwide, advancing research agendas that intersect fundamental biological sciences, clinical innovation, and public health. This strategic expansion is poised to cultivate transformative educational programs and consolidate global biomedical research endeavors.

The K-CLUB International Symposium’s focus on integrating scientific disciplines, engaging global expertise, and emphasizing translational research represents a paradigm shift in medical symposia. It reflects a comprehensive approach to healthcare innovation—one that prioritizes equitable access, global collaboration, and the seamless translation of scientific discovery into clinical reality. This pioneering effort by Korea University College of Medicine not only enhances the institution’s international stature but also contributes meaningfully to the collective endeavor of improving human health worldwide.

Overall, this landmark event underscored the intricate complexity of current global health challenges and demonstrated how collective academic and clinical expertise can forge innovative pathways forward. The stimulating discussions, vibrant exchange of ideas, and strong institutional commitments provide an inspiring model for how universities can lead in addressing humanity’s most pressing health concerns through interdisciplinary collaboration and international partnership.

Subject of Research: Global Health Innovation and Biomedical Convergence

Article Title: Korea University College of Medicine Launches K-CLUB International Symposium to Pioneer Global Health Collaboration

News Publication Date: July 4, 2024

Web References: https://mediasvc.eurekalert.org/Api/v1/Multimedia/df4b114a-f98e-4bef-abe3-90b9b9180822/Rendition/low-res/Content/Public

Image Credits: KU Medicine

Keywords: Health and medicine, Biomedical engineering

The recent study serves as a compelling case for how interconnected health domains can provide early warning systems and actionable intelligence against emerging infectious threats. Traditionally, arboviral outbreaks have been studied through siloed lenses—focusing either on human clinical cases or entomological monitoring alone. However, the One Health approach dissolves these barriers, fusing insights from wildlife virology, vector ecology, climate factors, and molecular epidemiology. The researchers’ findings reveal that USUV and WNV are not only co-circulating within Dutch ecosystems but are demonstrating complex spatiotemporal patterns influenced by bird migration, mosquito population dynamics, and climatic fluctuations.

Central to the investigation was the deployment of robust, multi-layered surveillance networks encompassing sentinel bird populations, mosquito traps strategically located across diverse habitats, and clinical data from veterinary and human health centers. Through meticulous sampling over multiple seasons, the team was able to detect viral RNA in avian species known as amplifying hosts, such as common blackbirds and various songbirds, alongside genomic sequencing that traced viral lineages back to both indigenous and migratory bird-associated strains. This genetic data illuminated the potential for viral introduction from southern Europe, especially during migratory periods, highlighting how global movement patterns inflect local disease ecology.

Meteorological variables played a pivotal role in modulating vector competence and virus replication rates. Periods of warmer temperatures and extended drought conditions, observed concurrently with heightened mosquito abundance, created conducive environments for enhanced virus transmission cycles. These climate-driven ecological shifts underscore the increasing vulnerability of northern Europe to arboviral emergence as global temperatures rise and weather patterns become more erratic. By overlaying entomological data with regional climate models, researchers demonstrated predictive capabilities that could inform public health interventions and vector control strategies.

Intriguingly, the study unveils differential pathogenicity and transmission dynamics between USUV and WNV. While both viruses share similar transmission cycles involving ornithophilic mosquitoes and bird reservoirs, their impact on host species and outbreak severity diverges. USUV, for instance, has been implicated in widespread mortality among avian species in various European countries, whereas WNV, although occasionally lethal to birds, poses a more considerable threat to human neurological health. The nuanced understanding of how these viruses coexist and sometimes compete within shared ecological niches provides critical insights for risk assessment.

Molecular analyses revealed the presence of distinct viral clades corresponding to different introduction events and local evolutionary pressures. This genetic heterogeneity implicates multiple, recurrent introductions facilitated by migratory birds rather than singular establishment events, complicating eradication efforts. The recombination and mutation rates observed suggest that ongoing viral adaptation may shape future epidemic potential, necessitating continuous genomic surveillance. By monitoring these genomic shifts, the scientific community can remain vigilant against the emergence of more virulent or transmissible strains.

The collaborative framework adopted by the team transcended traditional disciplinary boundaries, uniting epidemiologists, virologists, entomologists, ornithologists, and climatologists. Such interdisciplinary cooperation enabled a comprehensive approach to understanding how human activity, biodiversity, and environmental change converge to influence viral dynamics. This paradigm exemplifies a model for tackling other zoonotic and vector-borne diseases with pandemic potential, emphasizing the value of integrative approaches in global health security.

Importantly, the investigation’s temporal scope allowed for the tracking of annual fluctuation in virus prevalence, highlighting periods of heightened risk corresponding with specific ecological and climatic triggers. This temporal mapping can empower local health authorities to optimize surveillance timing and resource allocation, thus enhancing early detection and prompt response. Moreover, the integration of veterinary health data furnished an early indicator of viral circulation before human cases emerged, underscoring the sentinel role of animal health monitoring in human disease prevention.

From a policy perspective, the findings urge the incorporation of One Health strategies into national and regional disease control frameworks. Given the transboundary nature of arboviral pathogens, coordination between neighboring countries and international agencies becomes indispensable. The study’s revelations about viral gene flow and ecological drivers can inform border health security, vector control policies, and wildlife conservation efforts, reflecting the interconnectedness of ecosystem health and human well-being.

The ecological implications extend beyond immediate human health concerns. Avian population declines attributable to USUV outbreaks threaten biodiversity and disrupt ecosystem services, such as insect population regulation and seed dispersal. The cascading effects on ecosystem balance reinforce the urgency of surveillance and mitigation efforts. Protecting wildlife health is, therefore, not only a conservation imperative but an essential component of maintaining resilient ecosystems that underpin human societies.

On the technological front, the application of advanced molecular diagnostics and next-generation sequencing unlocked unprecedented detail about virus-host interactions and environmental reservoirs. Such technological sophistication empowers real-time monitoring and rapid response capabilities, critical in an era where emerging infectious diseases can spread swiftly across continents. The incorporation of digital data analytics and spatial mapping further enhanced the ability to visualize and predict outbreak patterns, offering valuable tools for epidemiological modeling.

Public awareness and education emerge as critical but oft-overlooked pillars of controlling emerging arboviruses. The study’s dissemination highlights the need for community engagement, especially in urban and peri-urban environments where human exposure to vector populations is significant. Emphasizing preventive measures—such as reducing stagnant water bodies breeding mosquitoes and promoting personal protection—can mitigate the risk of virus transmission to human populations.

The investigation also opens avenues for vaccine research and therapeutic development. Understanding strain diversity and genetic evolution provides vital clues for designing broadly protective interventions against flaviviruses. While no vaccines currently exist for USUV in humans, the study’s comprehensive data may catalyze efforts toward immunization strategies, particularly for high-risk groups in endemic areas.

As climate change continues to reshape the geographical boundaries of vector-borne diseases, this study serves as a harbinger of what may become a new norm in temperate regions. The northward advancement of vectors such as Culex mosquitoes and the accompanying viruses emphasize the urgency of establishing sustainable surveillance infrastructure, strengthening cross-sector collaborations, and investing in research capacity to preempt outbreaks.

In conclusion, the Dutch experience described in this landmark One Health study illuminates the multifaceted and dynamic nature of USUV and WNV emergence in Europe. Through rigorous integration of cross-disciplinary data streams, it crafts a sophisticated narrative of viral ecology shaped by complex biotic and abiotic forces. Such insights are imperative as the world grapples with the accelerating pace of zoonotic spillover events, underscoring the maxim that the health of people is inexorably tied to the health of animals and the environment.

Subject of Research: Emergence and dynamics of Usutu virus and West Nile virus in the Netherlands analyzed through a One Health approach.

Article Title: One Health approach uncovers emergence and dynamics of Usutu and West Nile viruses in the Netherlands.

Article References:
Münger, E., Atama, N.C., van Irsel, J. et al. One Health approach uncovers emergence and dynamics of Usutu and West Nile viruses in the Netherlands. Nat Commun 16, 7883 (2025). https://doi.org/10.1038/s41467-025-63122-w

Image Credits: AI Generated

At the heart of arenavirus infectivity lies the spike complex, a sophisticated glycoprotein assembly protruding from the viral envelope. This complex is indispensable for mediating viral attachment to cellular receptors and facilitating membrane fusion, ultimately enabling the virus to release its genetic material into host cells. Though the spike structures of Old World arenaviruses have been resolved through advanced imaging, a gap has persisted in our understanding of New World arenavirus spikes, where sequence variation and structural differences could underpin distinct viral behaviors. Addressing this gap, Cohen-Dvashi, Katz, and Diskin employed single-particle cryo-electron microscopy (cryo-EM) to capture high-resolution images of the isolated spike complex of the Sabiá virus, achieving unprecedented clarity at resolutions of 2.6 and 2.9 angstroms for two distinct conformational states.

The researchers uncovered two primary conformations representing critical phases of the viral entry process. The first, a “closed” state, approximates the native, pre-fusion configuration of the spike complex. This closed form is characterized by a tightly packed assembly that appears to shield key fusion machinery elements from premature activation and immune recognition. Achieving 2.6 Å resolution, the detailed architecture revealed intricate folding patterns and glycosylation sites that likely contribute both to stability and immune evasion. The second conformational snapshot depicts an “open” state at 2.9 Å resolution, corresponding to a transient intermediate that the spike assumes during membrane fusion and cellular entry. This distinction between closed and open states illuminates the dynamic structural rearrangements necessary for the virus to effectively invade host cells.

A novel finding of this study is the dependence of the spike’s conformational shifts on two critical environmental cues encountered during infection: acidic pH and the presence of a metal ion. Sabiá virus, like other enveloped viruses, exploits the acidic milieu within host endosomes to trigger conformational changes necessary for fusion. The data reveal that a yet unidentified metal ion stabilizes the open conformation, facilitating exposure of the fusion peptide and promoting membrane merger. This metal-dependent modulation suggests a uniquely intricate mechanism of viral entry, contrasting with previously characterized arenaviruses that do not appear to rely on such cofactors. Identifying this metal ion could present new avenues for therapeutic intervention by targeting viral entry pathways.

Intriguingly, these new structural insights hint at broader evolutionary and functional divergences within arenavirus clades. While Old World arenaviruses and New World clade C viruses share several conserved features in their spike complexes, clade B arenaviruses—including Sabiá—demonstrate distinct structural rearrangements modulated by metal binding and pH sensitivity. This functional divergence may reflect adaptation to different reservoirs and transmission cycles, potentially accounting for variations in pathogenicity and host range. Understanding these distinctive features enhances our grasp of arenavirus biology and highlights the necessity to consider clade-specific mechanisms when designing antiviral strategies.

The application of cryo-EM proved essential in visualizing these delicate conformations without introducing artifacts inherent to crystallography. By flash-freezing isolated spikes and capturing thousands of particle images, the team reconstructed three-dimensional models that elucidate subtle shifts within the glycoprotein domains. Notably, these structures provide direct visualization of receptor-binding sites, fusion loops, and the interplay of subunits that orchestrate entry. The precision of the 2.6 and 2.9 Å maps allowed identification of key amino acid residues involved in receptor engagement and structural stability, offering targets for future drug design.

Beyond characterizing static structures, the authors explored the biochemical triggers underlying the transition between closed and open states. Experiments revealed that lowering pH alone induced partial conformational changes but was insufficient to fully open the spike. Only in the presence of a specific metal ion did the spike adopt the fully open conformation necessary for membrane fusion. This nuanced interplay suggests a sophisticated viral strategy that ensures fusion only occurs within precise intracellular compartments, minimizing premature activation and improving infectivity. The identity of the metal ion remains elusive, but common candidates include divalent cations such as calcium, magnesium, or manganese, necessitating further biochemical probing.

This study also underscores the potential for metal ion chelators or pH-modifying agents as adjunctive therapies to disrupt Sabiá virus entry. By interfering with metal binding or local pH conditions, pharmacological agents could lock the spike complex in an inactive conformation, preventing fusion. Such strategies hold promise given the current absence of approved antivirals targeting New World arenaviruses. Moreover, the molecular details generated here enable rational design of fusion inhibitors or neutralizing antibodies aimed at structurally conserved or functionally critical regions of the spike.

Considering the broader implications, these findings could inform vaccine development efforts by pinpointing antigenic sites that elicit potent immune responses. The conformational states characterized reveal epitopes that are either exposed or hidden depending on the spike’s configuration, guiding immunogen design for maximal efficacy. Additionally, understanding the mechanisms of viral entry sheds light on how Sabiá virus and related arenaviruses evade host immunity during early infection stages, explaining the rapid progression and high mortality associated with hemorrhagic fever cases.

From a public health perspective, the enhanced understanding of Sabiá virus’s molecular biology is timely. South America remains a hotspot for emerging arenaviruses, driven by ecological changes and human encroachment into wildlife habitats. Enhanced surveillance combined with molecular characterizations like this one are crucial for preparedness and response to future outbreaks. The metal-dependent entry mechanism might also serve as a biomarker for rapid diagnostics or risk assessment.

The meticulous structural work by Cohen-Dvashi and colleagues opens avenues for targeted research into arenavirus fusion inhibitors. Such inhibitors, which have revolutionized treatment in other viral diseases like HIV and influenza, could be next-generation tools against hemorrhagic fever viruses. Moreover, the unique metal-ion dependency points to potentially exploitable vulnerabilities that differ from other arenavirus clades, emphasizing the value of tailored therapeutic approaches rather than one-size-fits-all solutions.

In summary, this study significantly advances our molecular fascination of arenaviruses by delivering the first detailed structural portrayal of the spike complex from the New World Sabiá virus. The identification of two distinct functional conformations—closed and open—and their regulation by acidic pH in conjunction with an unidentified metal ion enrich our understanding of viral entry in these deadly pathogens. As structural virology intersects with biochemistry and cellular biology, these insights promise to stimulate innovative countermeasures against arenavirus-induced hemorrhagic fevers that continue to threaten global health.

Further research is warranted to identify the specific metal ion implicated, to validate the findings in the context of intact virions and infected cells, and to explore the potential of small molecules or antibodies to interrupt the spike’s activation pathway. This work not only elevates the Sabiá virus onto the structural virology stage but also inspires renewed efforts to combat New World arenavirus threats through precision medicine grounded in atomic-level characterization.

Subject of Research: Structural characterization of the Sabiá virus spike complex and its metal-dependent conformational changes during viral entry.

Article Title: Metal-induced conformational changes in the Sabiá virus spike complex.

Article References:
Cohen-Dvashi, H., Katz, M. & Diskin, R. Metal-induced conformational changes in the Sabiá virus spike complex. Nat Microbiol (2025). https://doi.org/10.1038/s41564-025-02075-8

Image Credits: AI Generated

Shigella flexneri, a notorious bacterial pathogen responsible for bacillary dysentery, has long been a scourge in both developed and developing regions, particularly in areas with compromised sanitation. The pathogen’s ability to cause severe gastrointestinal illness poses significant morbidity risks. Today, however, resistance to multiple antimicrobial agents has transformed this once-manageable infection into a more formidable challenge. The latest findings illustrate not only the scope of resistance but also an unexpected ecological crossover that further complicates control efforts.

The outbreak, localized in New Mexico, presents a unique epidemiological complication: simultaneous infections in humans and non-human primate species inhabiting the same region. Previous studies have seldom reported such parallel infections, especially involving multidrug-resistant strains. This convergence highlights the permeability of species barriers and the insufficiency of traditional containment approaches that focus solely on human healthcare settings without considering wildlife reservoirs.

Initial epidemiological investigations traced the infection cluster back to several urban and peri-urban zones near primate research and rehabilitation centers. Detailed sampling and pathogen genomic analysis revealed striking genetic congruence between isolates obtained from infected human patients and those collected from captive and free-ranging non-human primates. This genetic overlap suggests recent transmission events, with multidrug resistance genes prominently featured in all samples.

Technological advances, including whole-genome sequencing and phylogenetic tracing, were crucial in mapping the pathogen’s evolution and transmission pathways. Such molecular characterization demonstrated that the outbreak strain harbored resistance determinants against commonly used antibiotics, notably fluoroquinolones, macrolides, and beta-lactams, severely limiting therapeutic options. Of particular concern was the presence of plasmid-mediated resistance genes, which facilitate horizontal gene transfer between bacterial populations, expediting the spread of resistance within and potentially beyond Shigella species.

Environmental sampling around affected zones further revealed the pathogen’s persistence in water sources and communal areas frequented by both humans and non-human primates. The pathogen’s environmental resilience and adaptability imply that typical sanitation measures might be insufficient to prevent ongoing transmission. This scenario underscores the critical importance of One Health approaches—integrative strategies that recognize the interconnected health of humans, animals, and ecosystems—in managing such outbreaks.

Clinically, the outbreak presented significant challenges. Patients experienced protracted dysentery symptoms, compounded by treatment failures attributable to multidrug resistance. Conventional antibiotic regimens proved largely ineffective, necessitating experimental therapeutic trials guided by antimicrobial susceptibility testing. The human health impact was exacerbated by the vulnerability of affected populations, including children and immunocompromised individuals, raising alarms for healthcare providers and policy-makers alike.

Parallel infections in non-human primates demonstrated not only the potential for zoonotic disease transmission but also an animal welfare crisis. Primate morbidity and mortality rates rose sharply in affected institutions, calling for urgent veterinary intervention. The phenomenon of a shared pathogen transcending species boundaries and resisting treatment signals a looming threat of broader ecological and public health consequences, should reservoirs expand or mutations increase virulence.

Resistance mechanisms identified in the bacterial isolates involved complex genetic architectures, including integrons and transposons, which facilitate adaptability amid antibiotic pressure. The integrative conjugative elements detected suggest that the bacteria are capable of acquiring and disseminating resistance traits in situ, complicating eradication attempts. These findings reinforce the necessity for vigilant antimicrobial stewardship across human and veterinary medicine.

The outbreak has sparked renewed dialogue regarding biosecurity protocols in settings where close human-animal interactions occur. Enhanced surveillance measures, rigorous sanitation standards, and targeted vaccination strategies for human populations may be critical components of containment. Additionally, routine monitoring of non-human primate health could serve as an early warning system for emerging infectious threats with zoonotic potential.

From a broader perspective, this outbreak in New Mexico exemplifies the profound implications of environmental disturbances, urban encroachment on wildlife habitats, and global travel on pathogen emergence. Climate change and habitat fragmentation may further stress ecosystems, creating conditions conducive to spillover events and fostering the evolution of drug-resistant pathogens, making research and preparedness indispensable.

The study also exemplifies the power of multidisciplinary collaboration, combining clinical microbiology, veterinary science, environmental analysis, and genomic epidemiology. Through such integrated research frameworks, scientists can unravel complex transmission networks and resistance patterns, informing more effective public health interventions and policies.

Moving forward, emphasis on the development of novel antimicrobial agents and adjunct therapies is critical. The current therapeutic arsenal is inadequate to respond to the rising tide of multidrug-resistant infections. Investment in research to identify bacterial vulnerabilities and to harness host immune modulation may offer promising avenues.

Moreover, public health agencies must enhance educational campaigns to raise awareness about antibiotic misuse and the risks posed by zoonotic diseases. Community engagement in high-risk areas is essential to promote hygienic practices, reduce exposure risks, and encourage prompt medical consultation when symptoms arise.

In summary, the multidrug-resistant Shigella flexneri outbreak documented in New Mexico delivers a stark reminder of the shifting landscape of infectious diseases in an interconnected world. It challenges conventional paradigms, pushing for holistic, One Health frameworks to anticipate, monitor, and mitigate similar threats. As resistance mechanisms evolve and ecosystems change, the alliance between human health and wildlife conservation becomes ever more critical.

The convergence of human and animal health crises observed here should catalyze global attention, urging stakeholders across sectors to devise resilient systems capable of confronting these multifaceted challenges. Only through sustained vigilance, innovative science, and collaborative commitment can we hope to control the spread of multidrug-resistant pathogens and safeguard the health of all species sharing our planet.

Subject of Research: Multidrug-resistant Shigella flexneri outbreak affecting humans and non-human primates.

Article Title: Multidrug-resistant Shigella flexneri outbreak affecting humans and non-human primates in New Mexico, USA.

Article References:
Shrum Davis, S., Salazar-Hamm, P., Edge, K. et al. Multidrug-resistant Shigella flexneri outbreak affecting humans and non-human primates in New Mexico, USA. Nat Commun 16, 4680 (2025). https://doi.org/10.1038/s41467-025-59766-3

Image Credits: AI Generated

Historically, babesiosis has been confined predominantly to the northeastern and upper midwestern regions of the United States, where the disease is recognized as an endemic zoonosis transmitted primarily by Ixodes scapularis. However, recent human case reports coupled with intensive entomological surveillance reveal a troubling geographical shift. The Mid-Atlantic region, with its diverse ecosystems and growing suburban interfaces, now shows a steadily increasing burden of this emerging infectious disease. The study provides robust evidence that Babesia microti is not only present in tick vectors in this area but is actively causing autochthonous, or locally acquired, human infections.

The research team utilized advanced molecular diagnostics, including polymerase chain reaction (PCR) techniques, to detect B. microti DNA in tick specimens collected over the studied period. Notably, this is the first large-scale documentation of B. microti in Ixodes keiransi ticks, a species whose role in pathogen transmission has been largely unexplored until now. This finding reshapes previous paradigms about vector competence and disease ecology by expanding the known potential vectors responsible for spreading babesiosis in nature.

The identification of Ixodes keiransi as a competent vector is particularly significant because it broadens the understanding of ecological niches and transmission cycles. These ticks demonstrate overlapping habitats with I. scapularis, potentially facilitating a more complex and efficient transmission network for B. microti in Mid-Atlantic environments. This discovery underscores the necessity for entomologists and public health officials to consider non-traditional vector species when developing surveillance and control strategies in emerging risk areas.

Human babesiosis presents a diagnostic challenge due to its often nonspecific symptoms, such as fever, chills, fatigue, and hemolytic anemia. This is compounded in clinical contexts by frequent coinfections with other tick-borne pathogens, especially Borrelia burgdorferi, the agent of Lyme disease. The study reports that approximately half of the B. microti-infected ticks were also concurrently infected with B. burgdorferi, with occasional triple infections including Anaplasma phagocytophilum. This multiplicity of pathogens can confound clinical diagnosis and complicate therapeutic interventions, highlighting the dire need for enhanced laboratory diagnostics and clinician awareness.

Accurate and timely diagnosis of babesiosis is critical because standard antibiotic regimens used for co-endemic diseases like Lyme disease are ineffective against Babesia. The protozoan nature of Babesia requires antiparasitic treatment, often a combination of atovaquone and azithromycin, rendering empirical treatment with doxycycline inadequate. Misdiagnosis or delayed treatment could lead to severe disease, notably in older adults, immunocompromised individuals, or those with other underlying health conditions.

The study’s comprehensive epidemiological analysis revealed that several health jurisdictions across the Mid-Atlantic states reported confirmed cases of locally acquired babesiosis for the first time during the study period. These areas include key districts in Virginia such as Mt. Rogers and New River Health Districts, regions in West Virginia, Maryland’s Baltimore metro region, and the District of Columbia. The intensity of reported cases correlated spatially with tick infection rates, suggesting that human exposure risk is linked to local vector pathogen prevalence.

Importantly, the researchers emphasize that babesiosis, while historically rare in this region, is gaining foothold and may already be underrecognized. The expansion of tick populations, changes in land use, climate variability, and increased human outdoor activity contribute synergistically to this emerging public health threat. As such, the region demands urgent investment in surveillance infrastructure that integrates both active tick monitoring and human case investigations.

Public health messaging must adapt to this evolving threat by informing healthcare providers to include babesiosis in the differential diagnosis for patients presenting with febrile illnesses during tick season. Enhanced awareness can expedite diagnostic testing, appropriate treatment, and better patient outcomes. The study further highlights the necessity of educating the public about preventive measures, including the use of repellents, protective clothing, and prompt tick removal to reduce infection risk.

This research also calls for interdisciplinary collaboration among entomologists, epidemiologists, clinicians, and public health authorities to develop integrated approaches for managing babesiosis and other emerging tick-borne diseases in newly affected areas. Alongside expanded diagnostic capabilities, vector control strategies tailored to regional ecologies and human behavior are essential to curtail disease spread.

In summary, the expansion of babesiosis into the Mid-Atlantic region represents a substantial shift in the landscape of tick-borne diseases in the United States. With the identification of new tick vectors and confirmation of locally acquired infections, this study paints a worrying picture of an emerging health threat that requires swift scientific attention and policy action. For communities, clinicians, and researchers alike, the message is clear: babesiosis is no longer confined to traditional hotspots and must be addressed proactively through surveillance, education, and clinical preparedness.

Subject of Research: Not applicable

Article Title: Emerging Babesiosis in the Mid-Atlantic: Autochthonous Human Babesiosis Cases and Babesia microti (Piroplasmida: Babesiidae) in Ixodes scapularis (Acari: Ixodidae) and Ixodes keiransi (Acari: Ixodidae) Ticks from Delaware, Maryland, Virginia, West Virginia, and the District of Columbia, 2009-2024

News Publication Date: April 29, 2025

Web References:

• Journal of Medical Entomology
• Article DOI: 10.1093/jme/tjaf054
• Entomological Society of America

Image Credits: Journal of Medical Entomology

Keywords: babesiosis, Babesia microti, Ixodes scapularis, Ixodes keiransi, tick-borne diseases, vector-borne pathogens, Mid-Atlantic region, Lyme disease coinfection, tick surveillance, emerging infectious diseases